Address: 13 Windsor Street, Islington, London N1 8QG,United Kingdom
Tel: +44(0)20 7288 7008
An elegant corporate events venue for business meetings & private conferences in Islington, London.
Many clients comment on how well their functions turn out at The Window. The combination of the light, spacious ambience and the friendly, responsive events team, allows clients to step out of the ordinary “conference mode” and encourages creative thinking and open dialogue.
Whether it’s for a business conference, a product launch, training seminar or executive meeting, the flexible floor spaces add that extra imaginative flair and the personalised client service takes care of the details to ensure an event is a complete success.
Venu hire for corporate events or private events.
The Window offers four distinctive and complementary floor spaces with eight rooms to suit varying needs. The elegant entrance way, flanked by a rock garden and over-hanging balcony, welcomes clients into a light and spacious two tiered reception floor.
The top floor conference room provides the focal point for the event. Its panoramic view of the London skyline and trade mark 12ft window make this an impressive backdrop for corporate presentations. Third floor executive suite and meeting rooms are ideal for smaller meetings and presentations. Audio Visual Services are also available on request.
The dining area, supported by specialist in-house catering services, can also be used as a secondary conference floor. Its more informal and relaxed environment lends itself to break out groups, private meetings and informal gatherings. Additional private rooms are also available upon request.
The Window’s prime location is supported by good transport links with Angel and Highbury & Islington underground stations and an NCP car park, all within a 10 minute walk. Wheelchair access is provided to all floors and The Hilton Hotel is close by for delegates requiring overnight accommodation.
A roundup of some of the biggest stories coming out of the UK pharma industry, including AstraZeneca’s bid for cancer specialist Fusion Pharmaceuticals; the shutdown of Sanofi’s R&D site in…
Last year the UK-based pharma industry warned against the country’s waning competitiveness, condemning the government’s statutory scheme designed to control drug prices. UK-headquartered AstraZeneca joined the battle cry, claiming it…
The recent FDA decision to investigate the serious risk of patients developing new cancers after treatment with CAR-T therapies may have created some bad press around cell and gene therapies,…
A roundup of the biggest stories from UK pharma, including the latest agreement between the British government and industry on a renewed drug pricing clawback scheme; GSK’s search for deals…
AstraZeneca has made a bold move by offering its in-house digital clinical trial expertise to clinical research organisations (CROs) and other pharmaceutical companies via the launch of healthtech business Evinova.…
Since its creation over 20 years ago, the National Institute for Health and Care Excellence (NICE), the Health Technology Assessment (HTA) body for England and Wales, has forged a solid…
Could the UK’s re-joining of Horizon Europe, the EU’s EUR 95 billion research funding programme, be the latest sign that the country is ready to win back its global scientific…
The latest news from UK healthcare and life sciences, including the safety review of Novo Nordisk’s GLP-1 receptor agonists; VaxEquity’s grant to scale up RNA vaccine manufacturing; AstraZeneca/Quell Therapeutics cell…
Life sciences have been steadily losing ground in the UK with a significant drop in global R&D investments and a decreasing number of patients enrolled in clinical trials. The British…
Several macro-trends affected the pharmaceutical industry in 2022, impacting its inventory position, writes Matthew Bardell, managing director of specialist inventory consultants nVentic. Bardell highlights findings in a recent report –…
The latest news from UK healthcare and the life sciences, including a record rise in the number of people using private healthcare services due to significant strains on the National…
Airfinity’s Dr Patricia Gallego highlights the persistent threat that COVID-19 continues to present to patients and healthcare systems around the world and outlines the urgent need for more vaccine breakthroughs…
See our Cookie Privacy Policy Here
